SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-069234
Filing Date
2024-08-14
Accepted
2024-08-14 18:19:43
Documents
2
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2233
2 POWER OF ATTORNEY ea021142402ex24-1_citius.htm EX-24.1 7182
  Complete submission text file 0001213900-24-069234.txt   11431
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Reporting) CIK: 0001506251 (see all company filings)

State of Incorp.: NV | Fiscal Year End: 0930
Type: 3 | Act: 34 | File No.: 001-41534 | Film No.: 241209993
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
CITIUS ONCOLOGY, INC. (Issuer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)